Metabolomics approach for multibiomarkers determination to investigate dengue virus infection in human patients

  • Nurul Shahfiza
  • Hasnah Osman
  • Tang Thean Hock
  • Abdel-Hamid Zaki Abdel-Hamid


Background: Dengue is one of the major public health problems in the world, affecting more than fifty million cases in tropical and subtropical region every year. The metabolome, as pathophysiological end-points, provide significant understanding of the mechanism and progression of dengue pathogenesis via changes in the metabolite profile of infected patients. Recent developments in diagnostic technologies provide metabolomics for the early detection of infectious diseases. Methods: The mid-stream urine was collected from 96 patients diagnosed with dengue fever at Penang General Hospital (PGH) and 50 healthy volunteers. Urine samples were analyzed with proton nuclear magnetic resonance (1H NMR) spectroscopy, followed by chemometric multivariate analysis. NMR signals highlighted in the orthogonal partial least square-discriminant analysis (OPLSDA) S-plots were selected and identified using Human Metabolome Database (HMDB) and Chenomx Profiler. A highly predictive model was constructed from urine profile of dengue infected patients versus healthy individuals with the total R2Y (cum) value 0.935, and the total Q2Y (cum) value 0.832. Results: Data showed that dengue infection is related to amino acid metabolism, tricarboxylic acid intermediates cycle and β-oxidation of fatty acids. Distinct variations in certain metabolites were recorded in infected patients including amino acids, various organic acids, betaine, valerylglycine, myoinositol and glycine. Conclusion: Metabolomics approach provides essential insight into host metabolic disturbances following dengue infection.


Agrawal DK, Tandon P, Chaturvedi UC, Kumar A (1978) Biochemical study of certain enzymes and metabolites of the carbohydrate metabolism in the skeletal muscle of the dengue virus-infected mice. J Gen Virol 40: 399–408

Ahmad Nizal MG, Rozita H, Mazrura S, Zainudin MA, Hidayatulfathi O, Faridah MA et al. (2012) Dengue infections and circulating serotypes in Negeri Sembilan, Malaysia. Malays J Pub Heal Med 12: 21–30

Ashley EA ( 2011) Dengue fever. Trends Anesth Crit Care 1: 39–41

Birungi G, Chen SM, Loy BP, Ng ML, Li SFY (2010) Metabolomics approach for investigation of effects of dengue virus infection using the EA.hy926 cell line. J Prot Res 9: 6523–6634

Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG, Moyes CL, Farlow AW, Scott TW, Hay SI (2012) Refining the global spatial limits of dengue virus transmission by evidencebased consensus. PLoS Negl Trop Dis 6: e1760. doi:10.1371/journal. pntd.0001760

Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, et al. (2013) The human urine metabolome. PLOS ONE 8: e73076. Doi: 10.1371

Davies SE, Chalmers RA, Randall EW, Iles RA (1988) Betaine metabolism in human neonates and developing rats. Clin Chim Acta 178: 241–249

Fadilah SAW, Sahrir S, Mazlam MZ, Raymond AA (2000) A comparison of the pattern of liver involvement in dengue hemorrhagic fever with classic dengue fever. Southeast Asian J Trop Med Public Health 31: 259–263

Giri S, Agarwal MP, Sharma V, Singh A (2008) Acute hepatic failure due to dengue, A case report 2008. http// content/1/1/204

Hicks J, Sivakolundu S, Colson K (2011) Metabolomics guide user manual version 005. Bruker Biospin. Billerica, USA

Hunsperger EA, Yoksan S, Buchy P, Nguyen VC, Sekaran SD, Enria DA, Pelegrino JL, et al (2009) Evaluation of commercially available anti-dengue virus immunoglobulin M tests. Emerg Infect Dis 15: 436– 439. doi: 10.3201/eid1503.080923

Kim YS, Maruvada P (2008) Frontiers in metabolomics for cancer research, proceedings of a National Cancer Institute workshop. Metabolomics 4: 105–113

Martina BEE, Koraka P, Osterhaus ADME (2000) Dengue virus pathogenesis, an integrated view. Clin Microbiol Rev 22: 564–581

Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, Lye DC (2012) Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic, A case control study. PLoS Negl Trop Dis 6: e1641. doi: 10.1371

Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC (1998) Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, NA/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats. J Diabetes Complications 12: 154–162

Shahfiza N, Hock TT, Hashem H, Abdel-Hamid AZ (2015) Metabolomics for charachterization of gender differences in patients invected with dengue virus. Asian Pac J Trop Med 8: 451–456

Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LTT (2000) Raengsakulrach B, Loan H, et al. Neurological manifestations of dengue infection. Lancet 355: 1053–1059

van der Greef J, Hankemeier T, McBurney RN (2006) Metabolomicsbased system. biology and personalized medicine, Moving towards n=1 clinical trials? Pharmacogenomics 7: 1087–1094

van Gool AJ, Henry B, Sprengers ED (2010) From biomarker strate- gies to biomarker activities and back. Drug Discov Tod 15: 121–126.

Wang Y, Liu Tb, Delmas G, Park S, Perlin D, Xue C (2011) Two major inositol transporters and their role in cryptococcal virulence. Eukaryot Cell 10: 618–628

Wannemacher RW, Klainer AS, Dinterman RE, Beisel WR (1976) The significance and mechanism of an increased serum phenylalaninetyrosine ratio during infection. Am J Clin Nutr 29: 997–1006

Wiklund S, Johansson E, Sjöström L, Mellerowicz EJ, Edlund U, Shockcor JP, et al. (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Analyt Chem 80: 115–122

World Health Organization (WHO) (2016) Dengue and severe dengue, media centre, fact sheet, updated April 2016